SCHEMBL1583301

SCHEMBL1583301

C#CN(C(C)C)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2562820 0.67
SCHEMBL17052536 0.67
SCHEMBL11866818 0.61
SCHEMBL25306 0.61
SCHEMBL8706212 0.61
SCHEMBL835953 0.61
SCHEMBL28239024 0.59 TSHR (0.35)
SCHEMBL1583205 0.59
Carbon Monoxide SCHEMBL6472869 0.57
SCHEMBL175266 0.56

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3368593-B1 IMPROVED BINDER COMPOSITIONS AND USES THEREOF KNAUF INSULATION SPRL (BE) 2023-12-06 EP claimed
EP-3870236-B1 NANOPARTICLE ENCAPSULATION TO TARGET G PROTEIN-COUPLED RECEPTORS IN ENDOSOMES TAKEDA PHARMACEUTICALS CO (JP) 2023-08-09 EP claimed
EP-3571293-B1 A THERMORESPONSIVE MICROCARRIER SYSTEM AND USES THEREOF AGENCY SCIENCE TECH & RES (SG) 2023-04-12 EP claimed
EP-3720890-B1 USE OF ANTIMICROBIAL ETHYLENE COPOLYMERS FOR PACKAGING APPLICATIONS SABIC GLOBAL TECHNOLOGIES BV (NL) 2022-12-28 EP claimed
EP-3368207-B1 ENCAPSULATION ENCAPSYS LLC (US) 2021-12-01 EP claimed
EP-3227263-B1 CXCR7 RECEPTOR MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2019-04-10 EP claimed
EP-2951216-B1 ANTI-MICROBIAL POLYMER FACHHOCHSCHULE MUENSTER (DE) 2018-07-18 EP claimed
EP-2415490-B1 SURFACE-TREATING AGENT, FILTERING MATERIAL FOR FILTER, AND BLOOD TREATMENT FILTER TERUMO CORP (JP) 2018-06-20 EP claimed
EP-3129418-B1 WATER SOLUBLE CROSS-LINKED BLOCK COPOLYMERS KEMIRA OYJ (FI) 2018-06-06 EP claimed
EP-3004082-B1 CXCR7 RECEPTOR MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2017-08-02 EP claimed
WO-2008107321-A1 HETEROCYCLIC COMPOUNDS USED AS ANTI-NEOPLASIC AGENTS OR CELL PROLIFERATION INHIBITORS CEREP (FR) 2008-09-12 WO claimed
EP-1416933-B1 SUBSTITUTED PIPERIDINES AS MODULATORS OF THE MELANOCORTIN RECEPTOR AMGEM INC (US) 2008-01-02 EP claimed
EP-1265873-B1 4-OXO-1,4-DIHYDRO-3-CINNOLINECARBOXAMIDES AS ANTIVIRAL AGENTS UPJOHN CO (US) 2003-10-15 EP claimed
EP-0793656-B1 NOVEL BENZYL PYRIMIDINES BASILEA PHARMACEUTICA AG (CH) 2003-03-26 EP claimed
EP-1159279-B1 4-OXO-4,7-DIHYDRO-THIENO[2,3-B]PYRIDINE-5-CARBOXAMIDES AS ANTIVIRAL AGENTS UPJOHN CO (US) 2002-10-16 EP claimed
EP-0430035-B1 Use of benzothiazepine for the preparation of a medicament for treating seizures HOECHST MARION ROUSSEL INC (US) 1996-06-26 EP claimed
EP-0303387-B1 KYNURENIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF NEURODEGENERATIVE DISORDERS MERCK SHARP & DOHME LTD. (GB) 1993-04-21 EP claimed
EP-0170460-B1 Derivatives of N-[2-(tetrahydro-3,5-dioxo-1H-pyrrolizin-7a(5H)-yl)ethyl]amine WARNER-LAMBERT COMPANY (US) 1989-05-03 EP claimed
EP-0033183-B1 PHENYLIMINOMETHYL-3-PYRIDINE DERIVATIVES, THEIR PREPARATION AND USE SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1984-07-04 EP claimed
EP-0008145-B1 USE OF PHENYLIMINOMETHYLPYRIDINE DERIVATIVES AS FUNGICIDES AND PLANT GROWTH REGULANTS COMPOSITIONS CONTAINING SUCH DERIVATIVES AND PHENYLIMINOMETHYLPYRIDINE DERIVATIVES AND THEIR PREPARATION SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1984-02-01 EP claimed